SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001193125-24-137218 from iSHARES TRUST (CIK 0001100663)

iSHARES TRUST (CIK 0001100663)
Date: May 13, 2024 · CIK: 0001100663 · Accession: 0001193125-24-137218

AI Filing Summary & Sentiment

File numbers found in text: 333-92935, 811-09729

Date
May 13, 2024
Author
/s/ Anne C. Choe
Form
CORRESP
Company
iSHARES TRUST (CIK 0001100663)

Letter

VIA EDGAR Division of Investment Management Securities and Exchange Commission Re: iShares Trust (the “Trust”) (Securities Act File No. 333-92935 and Investment Company Act File No. 811-09729) Post-Effective Amendment Nos. 2,716 & 2,717

Dear Ms. O’Neal:

This letter responds to your comments with respect to post-effective amendment (“PEA”) numbers 2,716 and 2,717 to the registration statement of the Trust filed pursuant to Rule 485(a) under the Securities Act of 1933 (“Securities Act”), on behalf of the following series of the Trust (each, a “Fund”):

iShares iBonds Dec 2034 Term Corporate ETF

iShares iBonds Oct 2034 Term TIPS ETF

The Securities and Exchange Commission staff (the “Staff”) provided comments to the Trust on April 22, 2024. For your convenience, the Staff’s comments are summarized below, and each comment is followed by the Trust’s response. Capitalized terms have the meanings assigned in each Fund’s Prospectus unless otherwise defined in this letter.

Comment 1: Please provide to the Staff a completed fee table and cost example at least five business days prior to the effective date of the registration statement.

Response: As requested, the Trust has provided a completed fee table and cost example for each Fund at least five business days prior to the effective date of the registration statement.

Comment 2: On page S-10 and page 20 under “Portfolio Managers,” please include the month and the year of each Fund’s inception in the parentheticals.

BRUSSELS CHICAGO FRANKFURT HOUSTON LONDON LOS ANGELES MILAN

MUNICH NEW YORK PALO ALTO PARIS ROME SAN FRANCISCO WASHINGTON

Securities and Exchange Commission

May 13, 2024

Page

Response: The Trust respectfully submits that use of the phrase “since inception” and the inclusion of each Fund’s inception year adequately discloses the “year service began” for the portfolio management team, consistent with the Form N-1A disclosure requirement of Item 5(b) adopted on October 26, 2022.

Comment 3: Please amend the disclosure in the “Management” section of the Prospectus to clarify that a discussion regarding the basis for the approval by the Board of the Investment Advisory Agreement with BFA will be available in the Fund’s Form N-CSR and posted on the Fund’s website.

Response: The Trust amended each Fund’s disclosure in the “Management” section of the Prospectus to the following:

A discussion regarding the basis for the approval by the Board of the Investment Advisory Agreement with BFA will be available in the Fund’s Form N-CSR filed with the SEC for the period ending October 31, and made available in the applicable financial statements posted on the Fund’s website at www.iShares.com.

Comment 4: In the SAI, please delete the statement that each Fund may reject or revoke a creation order if acceptance of the Deposit Securities would, in the opinion of counsel, have an adverse effect on the Fund or its shareholders (e.g., jeopardize the Fund’s tax status).

Response: The Trust respectfully submits that this disclosure has been discussed previously with the Staff and is consistent with prior comments received from David Orlic. We note that the current language reflects amendments from prior language that the Staff objected to and reflects additional conversations with the Staff in August 2022. (Please see the Trust’s letter filed with the Commission on August 26, 2022 in connection with PEA 2,549).

* * *

- 2 -

Securities and Exchange Commission

May 13, 2024

Page

Sincerely,
/s/ Anne C. Choe

Show Raw Text
CORRESP
1
filename1.htm

CORRESP

1875 K Street N.W.

Washington, DC 20006-1238

Tel: 202 303 1000

Fax: 202 303 2000

 May 13, 2024

 VIA
EDGAR

 Ms. Deborah O’Neal

 Division of
Investment Management

 Securities and Exchange Commission

100 F Street, N.E.

 Washington, DC 20549

Re:
 iShares Trust (the “Trust”)

(Securities Act File No. 333-92935 and

Investment Company Act File No. 811-09729)

Post-Effective Amendment Nos. 2,716 & 2,717

Dear Ms. O’Neal:

 This letter responds to your
comments with respect to post-effective amendment (“PEA”) numbers 2,716 and 2,717 to the registration statement of the Trust filed pursuant to Rule 485(a) under the Securities Act of 1933 (“Securities Act”), on behalf of the
following series of the Trust (each, a “Fund”):

 iShares iBonds Dec 2034 Term Corporate ETF

iShares iBonds Oct 2034 Term TIPS ETF

 The
Securities and Exchange Commission staff (the “Staff”) provided comments to the Trust on April 22, 2024. For your convenience, the Staff’s comments are summarized below, and each comment is followed by the Trust’s response.
Capitalized terms have the meanings assigned in each Fund’s Prospectus unless otherwise defined in this letter.

Comment 1:
 Please provide to the Staff a completed fee table and cost example at least five business days prior to the
effective date of the registration statement.

Response:
 As requested, the Trust has provided a completed fee table and cost example for each Fund at least five
business days prior to the effective date of the registration statement.

Comment 2:
 On page S-10 and page 20 under “Portfolio Managers,” please
include the month and the year of each Fund’s inception in the parentheticals.

BRUSSELS CHICAGO FRANKFURT HOUSTON LONDON LOS
 ANGELES MILAN

 MUNICH NEW
YORK PALO ALTO PARIS ROME SAN FRANCISCO WASHINGTON

 Securities and Exchange Commission

May 13, 2024

  Page
 2

Response:
 The Trust respectfully submits that use of the phrase “since inception” and the inclusion of each
Fund’s inception year adequately discloses the “year service began” for the portfolio management team, consistent with the Form N-1A disclosure requirement of Item 5(b) adopted on
October 26, 2022.

Comment 3:
 Please amend the disclosure in the “Management” section of the Prospectus to clarify that a
discussion regarding the basis for the approval by the Board of the Investment Advisory Agreement with BFA will be available in the Fund’s Form N-CSR and posted on the Fund’s website.

Response:
 The Trust amended each Fund’s disclosure in the “Management” section of the Prospectus to the
following:

 A discussion regarding the basis for the approval by the Board of the Investment Advisory Agreement with BFA
will be available in the Fund’s Form N-CSR filed with the SEC for the period ending October 31, and made available in the applicable financial statements posted on the Fund’s website at
www.iShares.com.

Comment 4:
 In the SAI, please delete the statement that each Fund may reject or revoke a creation order if acceptance of
the Deposit Securities would, in the opinion of counsel, have an adverse effect on the Fund or its shareholders (e.g., jeopardize the Fund’s tax status).

Response:
 The Trust respectfully submits that this disclosure has been discussed previously with the Staff and is
consistent with prior comments received from David Orlic. We note that the current language reflects amendments from prior language that the Staff objected to and reflects additional conversations with the Staff in August 2022. (Please see the
Trust’s letter filed with the Commission on August 26, 2022 in connection with PEA 2,549).

*     *    *

 - 2 -

 Securities and Exchange Commission

May 13, 2024

  Page
 3

Sincerely,

 /s/ Anne C. Choe

Anne C. Choe

cc:
 Marisa Rolland

Tim Kahn

 Michael Gung

Toree Ho

 Luis Mora

George Rafal

 Michael Foland

Michael James

 - 3 -